ASHLEY FROSCELLO: Open Payments
NPI 1790324424 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 31 payments from 11 companies in 2025. Trend: 2023 $701 · 2024 $472 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 11 | $172 |
| Astellas Pharma US Inc | 3 | $63 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $49 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Boston Scientific Corporation | 1 | $37 |
| SHIELD THERAPEUTICS INC | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| MILLICENT US INC | 1 | $21 |
Products named: ZURZUVAE, Veozah, Qelbree, Solyx SIS System, ACCRUFER, GEMTESA, SLYND, The Cologuard Plus Collection Kit.
Industry payments across AL — which companies pay providers there.
